Pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, HPC Biosciences has informed that the meeting of the Board of Directors of the Company will be held on Thursday, 10th November, 2022 to consider and approve the unaudited Financial Results for the half year ended on 30th September, 2022.
The above information is a part of company’s filings submitted to BSE.